Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP explain the approach and significance of the final order ...

In April 2026, the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) announced a significant shift in federal ...

Despite years of moves to loosen marijuana restrictions, pot is still illegal at the federal level (with some new exceptions) ...

On April 22, 2026, Acting Attorney General Todd Blanche issued a final order immediately placing both FDA-approved marijuana products ...

Rescheduling may give marijuana companies more room to market themselves, but the change is unlikely to result in an ...

These companies are major players in the U.S. marijuana market, and they all generated more than $1 billion in revenue last year.

The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance.

When the acting attorney general moved state-licensed medical marijuana and FDA-approved marijuana-containing products from ...

Rescheduling does matter greatly. Moving from Schedule I to Schedule III takes marijuana out of the same league as heroin, ...

Researchers at Johns Hopkins and UC San Diego used artificial intelligence to analyze comments in the public record ...